CA2458528C - Indane-1-ones substitues en c2 et leurs derives, leur procede de production et leur utilisation en tant que medicaments - Google Patents

Indane-1-ones substitues en c2 et leurs derives, leur procede de production et leur utilisation en tant que medicaments Download PDF

Info

Publication number
CA2458528C
CA2458528C CA2458528A CA2458528A CA2458528C CA 2458528 C CA2458528 C CA 2458528C CA 2458528 A CA2458528 A CA 2458528A CA 2458528 A CA2458528 A CA 2458528A CA 2458528 C CA2458528 C CA 2458528C
Authority
CA
Canada
Prior art keywords
alkyl
cycloalkyl
replaced
cooh
fluorine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2458528A
Other languages
English (en)
Other versions
CA2458528A1 (fr
Inventor
Gerhard Jaehne
Volker Krone
Martin Bickel
Matthias Gossel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Sanofi Aventis Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland GmbH filed Critical Sanofi Aventis Deutschland GmbH
Publication of CA2458528A1 publication Critical patent/CA2458528A1/fr
Application granted granted Critical
Publication of CA2458528C publication Critical patent/CA2458528C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/24—Sulfones; Sulfoxides having sulfone or sulfoxide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

L'invention concerne des indane-1-ones substitués en C2, leurs sels physiologiquement acceptables et leurs dérivés physiologiquement fonctionnels. L'invention se rapporte à des composés de formule (I), dans laquelle les groupes sont tels que définis dans la description, ainsi qu'à leurs sels physiologiquement acceptables et à leur procédé de production. Ces composés constituent par exemple des anorexigènes.
CA2458528A 2001-08-31 2002-08-17 Indane-1-ones substitues en c2 et leurs derives, leur procede de production et leur utilisation en tant que medicaments Expired - Fee Related CA2458528C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10142722A DE10142722A1 (de) 2001-08-31 2001-08-31 C2-substituierte Indan-1-one und ihre Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10142722.0 2001-08-31
PCT/EP2002/009207 WO2003020677A2 (fr) 2001-08-31 2002-08-17 Indane-1-ones substitues en c2 et leurs derives, leur procede de production et leur utilisation en tant que medicaments

Publications (2)

Publication Number Publication Date
CA2458528A1 CA2458528A1 (fr) 2003-03-13
CA2458528C true CA2458528C (fr) 2011-01-25

Family

ID=7697277

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2458528A Expired - Fee Related CA2458528C (fr) 2001-08-31 2002-08-17 Indane-1-ones substitues en c2 et leurs derives, leur procede de production et leur utilisation en tant que medicaments

Country Status (12)

Country Link
US (1) US6762326B2 (fr)
EP (1) EP1425267B1 (fr)
JP (1) JP4280164B2 (fr)
AR (1) AR036675A1 (fr)
AT (1) ATE472525T1 (fr)
AU (1) AU2002336085B2 (fr)
CA (1) CA2458528C (fr)
DE (2) DE10142722A1 (fr)
IL (1) IL160608A0 (fr)
MX (1) MXPA04001846A (fr)
PE (1) PE20030360A1 (fr)
WO (1) WO2003020677A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9920393D0 (en) 1999-08-27 1999-11-03 Medix Scient Uk Limited Plant extract mixtures and their uses
US7659313B2 (en) 2007-09-13 2010-02-09 Gateway Health Alliances, Inc. Methods and related compositions using specific indanes to reduce weight and inhibit lipase, α-amylase and α-glucosidase activity in mammals

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7700500L (sv) * 1976-01-20 1977-07-21 Hoechst Ag Tiazolidinderivat och forfarande for deras framstellning
DE2640358A1 (de) * 1976-09-08 1978-03-16 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung
DE2965279D1 (en) * 1978-07-27 1983-06-01 Schering Ag Indanyl derivatives, process for their preparation and pharmaceutical compositions containing these compounds
WO1989003681A1 (fr) * 1987-10-19 1989-05-05 Pfizer Inc. Tetralines, chromans et composes relatifs substitues destines au traitement de l'asthme
DE69317399T2 (de) * 1993-01-29 1998-07-02 American Cyanamid Co Aminocycloalkanobenzodioxole als beta-3 selektive adrenergische Wirkstoffe
DK0865419T3 (da) * 1995-12-06 2003-11-10 Venantius Ltd Dimere indanforbindelse og farmaceutiske anvendelser heraf
IL125071A0 (en) 1996-01-17 1999-01-26 Novo Nordisk As Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives their preparation and use
HU227021B1 (en) 1996-08-30 2010-05-28 Novo Nordisk As Glp-1 derivatives
JP4339402B2 (ja) 1996-12-31 2009-10-07 ドクター・レディーズ・ラボラトリーズ・リミテッド 新規なヘテロ環化合物、これらの製造方法及びこれらを含有する薬学的組成物、並びに糖尿病及び関連疾患の治療におけるこれらの使用
CA2294830A1 (fr) 1997-07-16 1999-01-28 John Bondo Hansen Derives de 1,2,4-thiadiazine fusionnee, leur preparation et utilisation
DE19831878C2 (de) * 1998-07-17 2001-05-17 Aventis Pharma Gmbh Polycyclische Thiazolidin-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19844547C2 (de) * 1998-09-29 2002-11-07 Aventis Pharma Gmbh Polycyclische Dihydrothiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19908539A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische 2-Amino-Dihydrothiazolsysteme, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
FR2796070B1 (fr) * 1999-07-06 2003-02-21 Lipha Derives de benzodiazepines utilisables dans le traitement de dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procedes de preparation
EP1078632A1 (fr) 1999-08-16 2001-02-28 Sanofi-Synthelabo Utilisation des inhibiteurs de monoamine oxydases dans la fabrication d'un médicament contre l'obésité

Also Published As

Publication number Publication date
US6762326B2 (en) 2004-07-13
CA2458528A1 (fr) 2003-03-13
DE10142722A1 (de) 2003-03-27
JP4280164B2 (ja) 2009-06-17
WO2003020677A3 (fr) 2003-07-31
JP2005525295A (ja) 2005-08-25
PE20030360A1 (es) 2003-05-16
US20030130345A1 (en) 2003-07-10
AU2002336085B2 (en) 2007-10-11
WO2003020677A2 (fr) 2003-03-13
AR036675A1 (es) 2004-09-29
DE50214511D1 (de) 2010-08-12
IL160608A0 (en) 2004-07-25
EP1425267B1 (fr) 2010-06-30
ATE472525T1 (de) 2010-07-15
EP1425267A2 (fr) 2004-06-09
MXPA04001846A (es) 2004-06-15

Similar Documents

Publication Publication Date Title
AU2002333447B2 (en) Use of polysubstituted indan-1-ol systems for producing drugs in the prophylaxis or treatment of obesity
US6717008B2 (en) Derivatives of C2-substituted indan-1-ol compounds, methods for their preparation and use
CA2458528C (fr) Indane-1-ones substitues en c2 et leurs derives, leur procede de production et leur utilisation en tant que medicaments
CA2458524C (fr) Indane-1-ones disubstitues en c2 et leurs derives, leur procede de production et leur utilisation en tant que medicaments
US6657086B2 (en) C2-substituted indan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals
US6919380B2 (en) Derivatives of C2-substituted indan-1-ol systems for the prophylaxis or treatment of obesity
US7763662B2 (en) Use of C2-substituted indan-1-ol systems for preparing medicaments for the prophylaxis or treatment of obesity
CA2458520C (fr) Systemes indan-1-ol polysubstitues, leur procede de production et leur utilisation comme medicaments
US6982353B2 (en) C2-disubstituted indan-1-ol compounds, their derivatives, processes for their preparation, and their use as pharmaceuticals
CA2458555A1 (fr) Utilisation de systemes d'indane-1-one substitues en c2 pour produire des medicaments permettant de prevenir ou traiter l'obesite

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed